id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-D-0014-0004,FDA,FDA-2005-D-0014,FDA,Notice,NAD-Notice of Availability of Data,2006-08-14T04:00:00Z,2006,8,2006-08-11T04:00:00Z,,2008-04-11T23:46:17Z,,0,0,090000648043e567
FDA-2005-D-0014-0003,FDA,FDA-2005-D-0014,Implementing a Collection Program for Source Plasma Containing Disease-Associated and Other Immunoglobulin (IgG) Antibodies,Supporting & Related Material,Guidance,2006-08-14T04:00:00Z,2006,8,,,2020-05-14T15:01:28Z,,0,0,090000648043e566
FDA-2005-D-0014-0002,FDA,FDA-2005-D-0014,Guidance,Supporting & Related Material,GDL-Guidance,2005-10-20T04:00:00Z,2005,10,,,2008-04-11T23:46:17Z,,0,0,090000648043e560
FDA-2005-D-0014-0001,FDA,FDA-2005-D-0014,FDA,Notice,NAD-Notice of Availability of Data,2005-10-20T04:00:00Z,2005,10,2005-10-19T04:00:00Z,2006-01-19T04:59:59Z,2008-04-11T23:46:17Z,,0,0,090000648043e54f